Cancer patients with blood clots gain no benefit from adding IVCF to fondaparinux
2011-07-10
(Press-News.org) Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
"This is the first prospective study to evaluate the treatment of venous thromboembolism (VTE) or blood clots in cancer patients and is a potentially practice-changing clinical trial," said principal investigator Dr. Myra Barginear, M.D., of The North Shore-LIJ Health System in New York, U.S.A.
The inferior vena cava is a large blood vessel in the abdomen that carries blood from the lower parts of the body back to the heart. A thin-mesh IVC filter can be placed in the inferior vena cava to prevent blood clots, or VTEs, from reaching the heart.
In the study, sixty-four patients with deep venous thrombosis (86%) and/or pulmonary embolism (55%) received fondaparinux. About half of patients received only fondaparinux, while the other half received fondaparinux in conjunction with an IVCF.
The median survival for patients receiving only fondaparinux was 493 days, compared with 266 days for patients on fondaparinux plus an IVCF. Meanwhile, a median 52% of patients on fondaparinux alone experienced a complete resolution of VTEs, compared with 45% of patients on fondaparinux plus IVCF.
The study suggests that there is no benefit from costly and invasive IVCF placement in patients who are receiving fondaparinux. The results also support future randomized trials to compare VTE resolution rates achieved with fondaparinux with low molecular weight heparin, another class of anticoagulant medication.
INFORMATION:
Dr. Myra Barginear will discuss the research with journalists during a WCLC press conference at 10 a.m. CET on Thursday, July 7. For individual interview requests, please call Renée McGaw at +31 20 549 3413 between July 3-7 in the press office at Amsterdam RAI, Amsterdam, the Netherlands. You may also email her at renee.mcgaw@ucdenver.edu
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC), based in Denver, Colorado, U.S.A., is the only global organization dedicated to the study of lung cancer. Founded in 1972, the association's membership includes more than 3,000 lung cancer specialists in 80 countries.
IASLC members promote the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and thoracic malignancies. IASLC disseminates information about lung cancer to scientists, members of the medical community and the public, and uses all available means to eliminate lung cancer as a health threat for the individual patients and throughout the world. Membership is open to any physician, health professional or scientist interested in lung cancer.
IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer. To learn more about IASLC please visit http://iaslc.org/
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-07-10
SAN DIEGO, CA – Creating a baseline for each youth athlete is a critical part of accurate future concussion assessment, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Differences in how females and males scored on a standardized concussion assessment tool were also investigated.
"Our research analyzed whether the new Sport Concussion Assessment Tool-2 (SCAT2) has any variability in data for youth athletes and whether gender makes a difference on the scores," said presenting researcher, ...
2011-07-10
SAN DIEGO, CA – Gender may be associated with an increased risk of cartilage lesions in anterior cruciate ligament (ACL) injured knees, according to research being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego.
"Having articular cartilage lesions (a hole or rough spot in the cartilage of the knee) is considered a predictor of future osteoarthritis-a debilitating joint condition," said lead author Jan Harald Roetterud, MD, from Akershus University Hospital, Lørenskog, Norway. "Our research is exciting because it highlights ...
2011-07-10
SAN DIEGO, CA – A smaller sized hamstring graft in an anterior cruciate ligament (ACL) reconstruction patient less than 20 years old may increase revision rates, according to research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego today.
"Hamstring grafts are commonly used in ACL reconstruction surgeries and vary in size, with the average being 8mm in diameter. Our research illustrated that when a patient was younger than 20 years old and had a graft of less than 8mm, they were more likely to have a future revision surgery," ...
2011-07-10
SAN DIEGO, CA – A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure.
"A history of malignancy has not been widely recognized as a significant risk factor for developing a VTE (venous thromboembolytic event) following knee arthroscopy," ...
2011-07-10
An international team of scientists has discovered that the female ancestor of all living polar bears was a brown bear that lived in the vicinity of present-day Britain and Ireland just prior to the peak of the last ice age -- 20,000 to 50,000 years ago. Beth Shapiro, the Shaffer Associate Professor of Biology at Penn State University and one of the team's leaders, explained that climate changes affecting the North Atlantic ice sheet probably gave rise to periodic overlaps in bear habitats. These overlaps then led to hybridization, or interbreeding -- an event that caused ...
2011-07-10
Foxp2, a gene involved in speech and language, helps regulate the wiring of neurons in the brain, according to a study which will be published on July 7th in the open-access journal PLoS Genetics. The researchers identified this functional link by first identifying the major targets of Foxp2 in developing brain tissue and then analysing the function of relevant neurons.
Foxp2 codes for a regulatory protein that provides a window into unusual aspects of brain function. In 2001, scientists discovered that mutations of the human gene cause a rare form of speech and language ...
2011-07-10
Researchers have uncovered a new target that could stop the growth of glioblastoma, a deadly form of brain cancer. In the July 8th issue of the journal Cell, a Cell Press publication, a new study identifies an enzyme found in glioma stem cells that allows them to grow and seed tumors. Importantly, normal stem cells, including those in the brain, don't appear to share that same dependency.
"When thinking about therapeutics [targeting cancer stem cells], you have to be careful that you aren't interfering with normal stem cells," said Christine Eyler of the Cleveland Clinic. ...
2011-07-10
Polar bears' unique characteristics allow them to survive in one of the most extreme environments on Earth, but that survival is now threatened as rising temperatures and melting ice reshape the Arctic landscape. Now it appears that the stress of climate change, occurring both long ago and today, may be responsible for surprising twists in the bears' history and future as well.
According to DNA evidence reported in the July 7th Current Biology, a Cell Press publication, polar bears and brown bears have mated successfully many times in the last 100,000 years. As a result ...
2011-07-10
An injection of stem cells into the heart could offer hope to many of the 850,000 Americans whose chest pain doesn't subside even with medicine, angioplasty or surgery, according to a study in Circulation Research: Journal of the American Heart Association.
Patients who received the new treatment reported half as many chest pain episodes and improved exercise capability compared to those who received a placebo.
The study was the first randomized, controlled trial of stem-cell therapy to show significant improvements in both chest pain and exercise tolerance – the two ...
2011-07-10
BLOOMINGTON, Ind. -- It seems we may have parasites to thank for the existence of sex as we know it. Indiana University biologists have found that, although sexual reproduction between two individuals is costly from an evolutionary perspective, it is favored over self-fertilization in the presence of coevolving parasites. Sex allows parents to produce offspring that are more resistant to the parasites, while self-fertilization dooms populations to extinction at the hands of their biological enemies.
The July 8 report in Science, "Running with the Red Queen: Host-Parasite ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cancer patients with blood clots gain no benefit from adding IVCF to fondaparinux
